The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study

BACKGROUND: A patient is considered to suffer from treatment resistant depression (TRD) when consecutive treatment with two products of different pharmacological classes, used for a sufficient length of time at an adequate dose, fail to induce a clinically meaningful effect (inadequate response). Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaffe, Dena H., Rive, Benoit, Denee, Tom R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686569/
https://www.ncbi.nlm.nih.gov/pubmed/31391065
http://dx.doi.org/10.1186/s12888-019-2222-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686569/
https://www.ncbi.nlm.nih.gov/pubmed/31391065
http://dx.doi.org/10.1186/s12888-019-2222-4

Ejemplares similares